Relationships of cell proliferation and expression of integrin subunits and type I collagen in skin fibroblasts with renal lesions in patients with IDDM

American Journal of Kidney Diseases

Volumn 31, Issue 2, 1998, Pages 293-300

  Jin, Dong Kyu ^b   Kim, Youngki ^b   Mauer, Michael ^b   Fioretto, Paola ^b   Vats, Abhay ^b   Fish, Alfred J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Extracellular matrix; Fibroblasts; Integrin

Indexed keywords

COLLAGEN TYPE 1; INTEGRIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; MALE; PROTEIN EXPRESSION; SKIN FIBROBLAST;

EID: 13144249138     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9469500     Document Type: Article

References (39)

1. + antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
2. + antiport activity of cultured skin fibroblasts from diabetics. Kidney Int 42:1184-1190, 1992
3. + antiporter. Kidney Int 50:1684-1693, 1996
4. Morocutti A, Earle KA, Sethi M, Piras G, Pal K, Richards D, Rodemann P, Viberti G: Premature senescence of skin fibroblasts from insulin-dependent diabetic patients with kidney disease. Kidney Int 50:250-256, 1996
5. Schwartz MA, Lechene C, Ingber DE: Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5β1, independent cell shape. Proc Natl Acad Sci U S A 88:7849-7853, 1991
6. Schwartz MA, Ingber DE, Lawrence M, Springer TA, Lechene C: Multiple integrin share the ability to induce elevation of intracellular pH. Exp Cell Res 195:533-535, 1991
7. Hynes RO: Integrins: Versatility, modulation and signaling in cell adhesion. Cell 69:22-25, 1992
8. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 120:577-585, 1993
9. Alberta SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 4:2969-2880, 1990
10. Ruoslahti E: Integrins. J Clin Invest 87:1-5, 1991
11. Chavers BM, Simonson J, Michael AF: A solid phase fluorescent immunoassay for the measurement of human urinary albumin. Kidney Int 25:576-578, 1984
12. Fioretto P, Steffes MW, Mauer SM: Glomerular structure in non-proteinuric insulin-dependent diabetic patients with various levels of albuminuria. Diabetes 43:1358-1364, 1994
13. Mauer SM, Sutherland DER, Steffes MW: Relationship of systemic blood pressure to nephropathology in insulin dependent diabetes mellitus. Kidney Int 41:736-740, 1992
14. Mauer SM, Goetz FC, McHugh LE, Sutherland DER, Barbosa J, Najarian JS, Steffes MW: Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes 38:516-523, 1989
15. Takada Y, Murphy E, Pil O, Chen C, Ginsberg MK: Molecular cloning and expression of the cDNA for α3 subunit of human α3β1 (VLA-3): An integrin receptor for fibronectin, laminin and collagen. J Cell Biol 115:257-266, 1991
16. Giancotti FG, Ruoslahti E: Elevated level of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 60:849-859, 1990
17. Leach RJ, Thayer MJ, Schafer AJ, Fournier RE: Physical mapping of human chromosome 17 using fragment-containing microcell hybrids. Genomics 5:167-176, 1989
18. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L: Isolation and characterization of full length cDNA clones for human α-, β-, and γ-actin mRNA: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 3:787-795, 1983
19. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
20. Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992
21. Ellis EN, Steffes MW, Goetz FC, Sutherland DER, Mauer SM: Glomerular filtration surface in type I diabetes mellitus. Kidney Int 29:889-894, 1986
22. Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
23. Barbosa J, Steffes MW, Sutherland DER, Connett JE, Rao KV, Mauer SM: The effect of glycemic control on early diabetic renal lesions. JAMA 272:600-606, 1994
24. Bangstad HF, Østerby R, Dahl-Jorgensen K, Berg KJ, Hartmann A, Hanssen KF: Improvement in blood sugar control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483-490, 1994
25. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease. N Engl J Med 320:1161-1165, 1989
26. Trevisan R, Viberti G: Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 126:342-349, 1995
27. Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y: Distribution of integrin subunits in human diabetic kidney. J Am Soc Nephrol 7:2636-2645, 1996
28. Ingber DE, Prusty D, Frangioni JV, Cragoe EJ Jr, Lechene C, Schwartz MA: Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J Cell Biol 110:1803-1811, 1990
29. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochem Biophys Acta 988:73-97, 1989
30. Ingber DE, Madri JA, Folkman J: Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol 23:387-394, 1987
31. Trevisan R, Yip J, Sarika L, Li LK, Viberti GC: Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. Am J Soc Nephrol 8:1133-1139, 1997
32. Hu Q, Moerman EJ, Goldstein S: Altered expression and regulation of the α5β1 integrin-fibronectin receptor leads to reduced amounts of functional α5β1 heterodimer on the plasma membrane of senescent human diploid fibroblasts. Exp Cell Res 224:251-263, 1996
33. van Det N, Verhagen NAM, Tamsma JT, Berden JHM, Bruijn JA, Daha MR, van der Woude FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
34. Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with memory. Proc Natl Acad Sci U S A 87:404-408, 1990
35. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J: Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem 264:380-388, 1989
36. Ignotz RA, Heino J, Massague J: Regulation of cell adhesion receptors by transforming growth factor-β. J Biol Chem 264:389-392, 1989
37. Kagami S, Border WA, Ruoslahti E, Noble NA: Coordinated expression of β1 integrins and transforming growth factor-β induced matrix protein in glomerulonephritis. Lab Invest 69:68-76, 1993
38. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
39. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90:1814-1818, 1993